10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-091526`
Period End Date	20200630
Filing Date	20200806
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	iova-20200630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 32 Cash Flow Statement 55 Stockholders Equity 37 Comprehensive Income 12

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$76.91M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.97M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$160.61M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$293.11M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$611.26M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.41M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.78M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$782.65M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$316.49M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$8.54M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$18.73M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$10.70M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$7.48M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$5.45M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$5.45M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$5.53M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$3.18M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	126.41M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	146.43M	shares	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$3.48M	USD	Point-in-time
Total Assets	`Assets`	$817.57M	USD	Point-in-time
Total Assets	`Assets`	$344.65M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	126.41M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	146.43M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$15.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.24M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$38.79M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$16.27M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$7.25M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$5.87M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$54.91M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$39.08M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$4.25M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$2.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$6.60M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$4.35M	USD	Point-in-time
Total Liabilities	`Liabilities`	$59.26M	USD	Point-in-time
Total Liabilities	`Liabilities`	$45.68M	USD	Point-in-time
Commitments and contingencies (Notes 8 and 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 8 and 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 146,434,810 and 126,411,808 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$6.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 146,434,810 and 126,411,808 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$5.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$317.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$220.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$869.35M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.46B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-703.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$300.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-570.61M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$758.31M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$298.97M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$243.31M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$397.42M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$466.19M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$434.93M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$817.57M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$344.65M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpense`	$106.23M	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$39.30M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$70.20M	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$49.27M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$28.21M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$10.87M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$19.95M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$14.35M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$90.15M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$63.63M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$134.44M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$50.16M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-63.63M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-50.16M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-90.15M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-134.44M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$2.61M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$5.65M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$609.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$1.82M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-84.50M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-63.02M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-132.61M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-47.55M	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.68	USD	2 Qtrs
Net Loss Per Share of Common Stock, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.47	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.38	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.02	USD	2 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	129,848.00	shares	2 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	123,491.00	shares	2 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	123,567.00	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	133,162.00	shares	1 Quarter

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-84.50M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-63.02M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-132.61M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-47.55M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$19.95M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$12.27M	USD	2 Qtrs
Noncash lease expense	`NonCashLeaseExpense`	$3.03M	USD	2 Qtrs
Noncash lease expense	`NonCashLeaseExpense`	$3.33M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$512.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$560.00K	USD	2 Qtrs
Gain on settlement of dispute	`GainLossRelatedToLitigationSettlement`	$336.00K	USD	2 Qtrs
Amortization of premiums on investments	`AmortizationOfDebtDiscountPremium`	$-2.43M	USD	2 Qtrs
Amortization of premiums on investments	`AmortizationOfDebtDiscountPremium`	$-17.00K	USD	2 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.06M	USD	2 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$515.00K	USD	2 Qtrs
Operating lease liabilities (Right-of-use assets)	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-3.74M	USD	2 Qtrs
Operating lease liabilities (Right-of-use assets)	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-2.65M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$9.95M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-7.10M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.73M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$18.81M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-101.93M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-62.88M	USD	2 Qtrs
Maturities of short-term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$263.10M	USD	2 Qtrs
Maturities of short-term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$216.68M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$201.13M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$534.72M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.26M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.61M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$59.72M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-323.65M	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$283.00K	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$95.00K	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$5.19M	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$3.47M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$567.00M	USD	Point-in-time
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$162.00M	USD	Point-in-time
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$567.39M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$572.30M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.38M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$146.72M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$210.00K	USD	2 Qtrs
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.15M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.36M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$166.14M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.15M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.36M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$166.14M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Unrealized gain on short-term investments	`UnrealizedGainLossOnShortTermInvestments`	$414.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`UnrealizedGainLossOnShortTermInvestments`	$97.00K	USD	2 Qtrs
Acquisitions of property and equipment included in accounts payable and accrued expense	`CapitalExpendituresIncurredButNotYetPaid`	$92.00K	USD	2 Qtrs
Acquisitions of property and equipment included in accounts payable and accrued expense	`CapitalExpendituresIncurredButNotYetPaid`	$5.21M	USD	2 Qtrs
Accrued offering costs in accrued expenses	`AccruedOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction`	$393.00K	USD	2 Qtrs

Stockholders Equity 37 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$758.31M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$243.31M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$397.42M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$466.19M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$434.93M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.54M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.43M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$12.27M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.95M	USD	2 Qtrs
Vesting of restricted shares issued for services	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$-1.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-165.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-94.00K	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-23.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-283.00K	USD	2 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.24M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.19M	USD	2 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.40M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.47M	USD	2 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$414.00K	USD	2 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-595.00K	USD	1 Quarter
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$234.00K	USD	1 Quarter
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$97.00K	USD	2 Qtrs
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$567.00M	USD	2 Qtrs
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$567.00M	USD	1 Quarter
Common stock sold in public offering, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	50,000.00	shares	Point-in-time
Cancellation of common shares from settlement of dispute	`StockCancelledDuringPeriodSharesOfCommonStock`	$-336.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-84.50M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-63.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-132.61M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-47.55M	USD	1 Quarter
Ending Balance	`StockholdersEquity`	$758.31M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$243.31M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$397.42M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$466.19M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$434.93M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-84.50M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-63.02M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-132.61M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-47.55M	USD	1 Quarter
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$414.00K	USD	2 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-595.00K	USD	1 Quarter
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$234.00K	USD	1 Quarter
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$97.00K	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-132.52M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-84.09M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-47.32M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-63.61M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.